20β-Dihydrodydrogesterone

• CAT Number: C000822
• CAS Number: 4243-73-6
• Molecular Formula: C₂₁H₃₀O₂
• Molecular Weight: 314.46
• Purity: ≥95%
• Synonyms: (9β,10α,20R)-20-Hydroxypregna-4,6-dien-3-one; 20β-Hydroxy-9β,10α-pregna-4,6-dien-3-one
• Appearance: White to Pale Yellow Solid
• Storage: 4°C
• IUPAC Name: (8S,9R,10S,13S,14S,17S)-17-[(1R)-1-hydroxyethyl]-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one
• InChI: InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4-5,12-13,16-19,22H,6-11H2,1-3H3/t13-,16+,17-,18+,19-,20-,21-/m1/s1
• InChIKey: IQPNZLYVKOVQGH-RKJOAILSSA-N
• SMILES: C[C@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2C=CC4=CC(=O)CC[C@@]34C)C)O

20β-Dihydrodydrogesterone (Cat No.:C000822) is a derivative of dydrogesterone, a synthetic progestogen commonly used in hormonal therapies and as a treatment for various gynecological conditions. This compound is structurally related to progesterone and acts as a potent progestogenic agent. It may have implications for reproductive health and hormone-related disorders. Detailed information about its specific applications, pharmacological effects, and clinical uses can be found in scientific literature. Research on 20β-Dihydrodydrogesterone contributes to the understanding of hormonal therapies and their potential roles in managing women’s health concerns.

Reference

Azizuddin, et al.: Pak J Pharm Sci, 28, 521-523 (2015)